Function Health, the 160+ biomarker testing membership platform, acquired Getlabs to enable at-home blood draw for its members — expanding its diagnostic infrastructure ahead of anticipated telehealth expansion. Historical articles may no longer reflect current regulatory status. Check the cited primary source.
Function Health, a longevity-focused health intelligence membership platform offering 160+ biomarker tests, has acquired Getlabs — a mobile phlebotomy platform that enables at-home blood draws through a network of trained phlebotomists.
We email you when the FDA or HHS makes a move on a peptide you care about. Every email links the official source. No spam, no sales.
We don't collect health information. Unsubscribe anytime. Privacy policy
The acquisition was reported by Fierce Healthcare. Financial terms were not disclosed.
Function Health was co-founded by Dr. Mark Hyman and Jonathan Swerdlin. The platform offers a membership model that provides access to a comprehensive laboratory panel — 160+ biomarkers — at a flat annual fee. Members receive detailed analysis and recommendations based on their results, with a focus on preventive and longevity-oriented health management.
Function Health has been one of the highest-profile companies in the longevity diagnostics space, raising significant capital and building a consumer base of health-conscious individuals seeking deeper insight into their biomarkers than standard primary care testing provides.
Getlabs is a mobile phlebotomy and diagnostics logistics platform that connects patients with mobile phlebotomists who can perform blood draws at the patient's home or other locations. The platform handles scheduling, quality control, and specimen transport to laboratory facilities.
The acquisition closes a friction point that has limited at-home diagnostic adoption: the need to visit a lab draw center. For Function Health specifically, the acquisition means members in supported markets can have their 160+ biomarker draws performed at home — removing one of the primary barriers to the membership model.
More broadly, this acquisition is consistent with the direction of the longevity and precision medicine market: vertically integrating the diagnostic stack, from biomarker panel design through blood draw through analysis and recommendations. As the market matures, platforms that control more of the patient experience are better positioned for retention and expansion.
Function Health is a benchmark competitor in the longevity intelligence space. Their vertical integration strategy — owning more of the diagnostic and analysis stack — illustrates the broader market shift toward integrated health-data platforms.
The acquisition signals continued investment in at-home health infrastructure as a competitive differentiator.
We email you when the FDA or HHS makes a move on a peptide you care about. Every email links the official source. No spam, no sales.
We don't collect health information. Unsubscribe anytime. Privacy policy
Function Health acquired Getlabs to enable at-home blood draws for its members, eliminating the need to visit a lab draw center for their 160+ biomarker testing panel. This reduces friction and improves the member experience.
Function Health is a longevity-focused membership platform offering 160+ biomarker tests at a flat annual fee. Co-founded by Dr. Mark Hyman and Jonathan Swerdlin, it provides detailed biomarker analysis for preventive and longevity health management.
Getlabs is a mobile phlebotomy platform that connects patients with trained phlebotomists for at-home blood draws. The platform handles scheduling, quality control, and specimen transport to laboratory facilities.